Free Trial

OptimizeRx (OPRX) Stock Forecast & Price Target

$12.30
-0.27 (-2.15%)
(As of 04:00 PM ET)

OptimizeRx - Analysts' Recommendations and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Moderate Buy
Based on 7 Analyst Ratings

Consensus Price Target

$16.00
30.08% Upside
High Forecast$20.00
Average Forecast$16.00
Low Forecast$13.00
TypeCurrent Forecast
5/24/23 to 5/23/24
1 Month Ago
4/24/23 to 4/23/24
3 Months Ago
2/23/23 to 2/23/24
1 Year Ago
5/24/22 to 5/24/23
Consensus Rating
Moderate Buy
Moderate Buy
Moderate Buy
Moderate Buy
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
6 Buy rating(s)
6 Buy rating(s)
7 Buy rating(s)
6 Buy rating(s)
Hold
1 Hold rating(s)
1 Hold rating(s)
1 Hold rating(s)
1 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$16.00$15.86$16.00$21.00
Forecasted Upside30.08% Upside35.83% Upside27.39% Upside19.09% Upside
Get OptimizeRx Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for OPRX and its competitors with MarketBeat's FREE daily newsletter.

OPRX Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

OPRX Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

OptimizeRx Stock vs. The Competition

TypeOptimizeRxComputer and Technology CompaniesS&P 500
Consensus Rating Score
2.86
2.59
2.49
Consensus RatingModerate BuyModerate BuyHold
Predicted Upside27.90% Upside187.37% Upside9.79% Upside
News Sentiment RatingNeutral News
Neutral News
Positive News

Recent Analyst Forecasts and Stock Ratings

DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
5/15/2024JMP Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetMarket Outperform ➝ Market Outperform$15.00 ➝ $16.00+23.65%
5/15/2024Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingBuy ➝ Buy$13.00 ➝ $13.00+24.05%
4/1/2024Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingOutperform ➝ Outperform$17.00+42.02%
1/3/2024Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageEqual Weight$15.00+6.84%
8/15/2023Roth Mkm
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetBuy ➝ Buy$31.00 ➝ $20.00+120.75%
8/15/2023Lake Street Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetBuy ➝ Buy$18.00 ➝ $13.00+3.42%
8/15/2023B. Riley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetBuy ➝ Buy$28.00 ➝ $18.00+43.20%
3/21/2023William Blair
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingOutperform
3/9/2023Roth Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
R. Baldry
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy
1/27/2023SVB Leerink
Subscribe to MarketBeat All Access for the recommendation accuracy rating
S. Davis
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOutperform
8/10/2022Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Jeffrey Garro
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower TargetNeutral$29.00 ➝ $16.00-28.09%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Thursday at 04:57 PM ET.

OPRX Frequently Asked Questions

What is OptimizeRx's stock forecast and purchase recommendation?

According to the research reports of 7 Wall Street equities research analysts, the average twelve-month stock price forecast for OptimizeRx is $16.00, with a high forecast of $20.00 and a low forecast of $13.00. The consensus rating for OptimizeRx stock is Moderate Buy based on the current 1 hold rating and 6 buy ratings for OPRX. Learn more on OPRX's analyst rating history.

Do Wall Street analysts like OptimizeRx more than its competitors?

Analysts like OptimizeRx more than other "computer and technology" companies. The consensus rating score for OptimizeRx is 2.86 while the average consensus rating score for "computer and technology" companies is 2.59. Learn more on how OPRX compares to other companies.

Does OptimizeRx's stock price have much upside?

According to analysts, OptimizeRx's stock has a predicted upside of 33.92% based on their 12-month stock forecasts.

What analysts cover OptimizeRx?

OptimizeRx has been rated by research analysts at JMP Securities, Royal Bank of Canada, and Stifel Nicolaus in the past 90 days.


Stock Forecasts and Research Tools

This page (NASDAQ:OPRX) was last updated on 5/23/2024 by MarketBeat.com Staff

From Our Partners